Bicocca Open Archive

Logo unimib boa
VILLA, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.133
NA - Nord America 2.049
EU - Europa 1.738
SA - Sud America 339
AF - Africa 56
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.328
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.950
IT - Italia 827
SG - Singapore 624
VN - Vietnam 482
CN - Cina 419
BR - Brasile 266
HK - Hong Kong 223
RU - Federazione Russa 194
DE - Germania 156
FR - Francia 94
IE - Irlanda 78
GB - Regno Unito 72
IN - India 66
BD - Bangladesh 63
SE - Svezia 62
CA - Canada 61
KR - Corea 55
ID - Indonesia 47
FI - Finlandia 41
NL - Olanda 39
ES - Italia 33
CH - Svizzera 31
PL - Polonia 28
AT - Austria 26
AR - Argentina 25
TR - Turchia 22
JP - Giappone 21
MX - Messico 18
PH - Filippine 18
ZA - Sudafrica 18
IQ - Iraq 15
EC - Ecuador 14
UA - Ucraina 13
LT - Lituania 12
PK - Pakistan 12
MA - Marocco 11
SA - Arabia Saudita 10
UZ - Uzbekistan 10
VE - Venezuela 9
AU - Australia 8
KE - Kenya 8
PE - Perù 8
BE - Belgio 7
CL - Cile 7
TH - Thailandia 6
EG - Egitto 5
IR - Iran 5
MY - Malesia 5
RO - Romania 5
CR - Costa Rica 4
JM - Giamaica 4
JO - Giordania 4
NP - Nepal 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
CO - Colombia 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
OM - Oman 3
PY - Paraguay 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
IL - Israele 2
KZ - Kazakistan 2
MK - Macedonia 2
RS - Serbia 2
SV - El Salvador 2
TN - Tunisia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
GR - Grecia 1
GT - Guatemala 1
KG - Kirghizistan 1
LB - Libano 1
LC - Santa Lucia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TO - Tonga 1
TT - Trinidad e Tobago 1
Totale 6.326
Salva come PNG Salva come JPEG
Città #
Singapore 344
Ashburn 297
Milan 292
San Jose 250
Hong Kong 207
Dallas 190
Ho Chi Minh City 145
Hanoi 137
Hefei 100
Ann Arbor 97
Los Angeles 90
New York 88
Frankfurt am Main 79
Dublin 76
Beijing 62
Seoul 51
Chicago 46
Santa Clara 42
Jakarta 37
The Dalles 37
Munich 35
Chandler 33
Toronto 31
Boardman 30
São Paulo 29
Rome 28
Buffalo 26
Council Bluffs 26
Lauterbourg 26
Desio 25
Moscow 25
Zurich 24
Columbus 23
Seveso 22
Fairfield 20
Helsinki 20
Kent 19
London 19
Montreal 18
Tokyo 18
Warsaw 18
Monza 17
Da Nang 16
Turku 16
Carate Brianza 15
Chennai 15
Haiphong 15
Houston 15
Stockholm 15
Nuremberg 14
Orem 14
Atlanta 13
Denver 12
Phoenix 12
Poplar 12
Shanghai 12
Vienna 12
Amsterdam 11
Genoa 11
Johannesburg 11
Rio de Janeiro 11
Turin 11
Ha Long 10
Lissone 10
Paris 10
Perugia 10
Seattle 10
Tashkent 10
Boston 9
Ankara 8
Biên Hòa 8
Can Tho 8
Lima 8
Manchester 8
Quezon City 8
Brooklyn 7
Brussels 7
Campinas 7
Cesano Maderno 7
Ithaca 7
Pune 7
Quận Bình Thạnh 7
Quận Một 7
San Diego 7
Seregno 7
Sesto San Giovanni 7
Wilmington 7
Baghdad 6
Brescia 6
Corsico 6
Curitiba 6
Florence 6
Forsyth 6
Lodz 6
Magenta 6
Nairobi 6
Princeton 6
Querétaro 6
Romola 6
Bari 5
Totale 3.740
Salva come PNG Salva come JPEG
Nome #
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 430
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib 405
Investigation of drug resistance and co-mutational landscape of ALK-positive tumors 364
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 354
Integrative multi-omics analysis enables a comprehensive characterization of prostate cancer and unveils metastasis-associated candidate biomarkers 353
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies 334
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 312
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 296
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 292
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients 281
Characterization of cancer subtypes associated with clinical outcomes by multi-omics integrative clustering 276
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 272
Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors 270
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 269
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 258
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 239
New advances in liquid biopsy technologies for anaplastic lymphoma kinase (Alk)—positive cancer 233
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 232
Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer 218
Abstract 987: Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 196
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models 190
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 162
Author Correction: Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer (npj Precision Oncology, (2025), 9, 1, (291), 10.1038/s41698-025-01088-0) 139
Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution 31
Palbociclib targets β-catenin for degradation and synergizes with KRAS or ERK5 inhibition in colorectal cancer preclinical models 23
Totale 6.429
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.170
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202269 5 6 4 4 10 5 8 3 7 6 3 8
2022/2023221 20 34 17 17 8 15 1 9 20 33 22 25
2023/2024477 41 22 22 20 59 94 73 16 34 23 30 43
2024/20251.551 52 94 88 78 105 58 98 43 181 255 156 343
2025/20263.897 485 322 402 496 365 182 517 148 255 350 135 240
2026/202771 71 0 0 0 0 0 0 0 0 0 0 0
Totale 6.429